REXAHN PHARMACEUTICALS INC - COM (RNN)

CUSIP: 761640101

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / COM
Total 13F shares
19,351,118
Share change
-3,203,249
Total reported value
$4,862,000
Price per share
$0.25
Number of holders
27
Value change
-$810,066
Number of buys
9
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 761640101?
CUSIP 761640101 identifies RNN - REXAHN PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REXAHN PHARMACEUTICALS INC - COM (RNN) as of Q2 2016

As of 30 Jun 2016, REXAHN PHARMACEUTICALS INC - COM (RNN) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,351,118 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Institutional Trust Company, N.A., NORTHERN TRUST CORP, HUDSON VALLEY INVESTMENT ADVISORS INC /ADV, KCG Holdings, Inc., Northeast Financial Consultants Inc, and Bank of New York Mellon Corp. This page lists 27 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.